Floatz logo

Acetylsalicylic Acid

Classical Hodgkin Lymphoma

The Methodist Hospital Research InstitutePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

36 Active assets in the Classical Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
DACARBAZINE
City of Hope Medical Center
Phase 3BB
VINBLASTINE
University of Washington
Phase 2BB
ETOPOSIDE
Masonic Cancer Center, University of Minnesota
Phase 3BB
Inno-206
Michael Spinner, MD
Phase 3BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3BB

View all 46 →

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant
A
Indicative ·
83 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →